08:39 AM EST, 12/09/2024 (MT Newswires) -- Health care stocks were steady premarket Monday as the Health Care Select Sector SPDR Fund (XLV) was marginally down and the iShares Biotechnology ETF (IBB) was inactive.

Arcellx ( ACLX ) shares were up 8.6% pre-bell Monday after the company said preliminary data from a phase 2 trial of anitocabtagene autoleucel in patients with relapsed or refractory multiple myeloma demonstrated a 97% overall response rate.